ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 59 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $603,083 | +123736.3% | 840,651 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $487 | -99.9% | 840,651 | -10.7% | 0.00% | -33.3% |
| Q3 2022 | $895,000 | -20.8% | 941,751 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $1,130,000 | -13.1% | 941,751 | -5.1% | 0.00% | 0.0% |
| Q1 2022 | $1,300,000 | +68.0% | 992,729 | +125.8% | 0.00% | +100.0% |
| Q4 2021 | $774,000 | -75.7% | 439,574 | -70.0% | 0.00% | -80.0% |
| Q3 2021 | $3,183,000 | -44.1% | 1,466,807 | -9.8% | 0.01% | -47.4% |
| Q2 2021 | $5,693,000 | +2262.2% | 1,626,698 | +7228.1% | 0.02% | +1800.0% |
| Q4 2020 | $241,000 | -91.4% | 22,198 | -91.9% | 0.00% | -93.8% |
| Q3 2020 | $2,814,000 | -57.9% | 273,201 | -14.7% | 0.02% | -62.8% |
| Q2 2020 | $6,686,000 | +2009.1% | 320,215 | +218.4% | 0.04% | +975.0% |
| Q4 2018 | $317,000 | – | 100,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $85,866,000 | 42.72% |
| Versant Venture Management, LLC | 7,003,892 | $146,241,265,000 | 21.01% |
| ACUTA CAPITAL PARTNERS, LLC | 1,746,500 | $36,467,000 | 10.54% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $10,022,000 | 5.33% |
| Ghost Tree Capital, LLC | 900,000 | $18,792,000 | 4.96% |
| RTW INVESTMENTS, LP | 6,790,027 | $141,776,000 | 3.99% |
| RA Capital Management | 7,801,641 | $162,898,000 | 3.17% |
| Avoro Capital Advisors LLC | 7,585,000 | $158,375,000 | 3.13% |
| FRAZIER MANAGEMENT LLC | 1,437,028 | $30,005,000 | 2.64% |
| Soleus Capital Management, L.P. | 218,723 | $4,566,000 | 2.60% |